These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10973879)

  • 1. Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.
    Wong IH; Lo YM; Lai PB; Johnson PJ
    Clin Chem; 2000 Sep; 46(9):1420-2. PubMed ID: 10973879
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
    Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
    Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma.
    Matsuda Y; Ichida T; Matsuzawa J; Sugimura K; Asakura H
    Gastroenterology; 1999 Feb; 116(2):394-400. PubMed ID: 9922321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific enzyme immunoassay for alpha-fetoprotein from hepatocellular carcinoma.
    Kohno T; Kitamura T; Tsuda K; Ishikawa E
    J Clin Lab Anal; 1990; 4(1):74-8. PubMed ID: 1690279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current considerations on the behavior of serum alpha-fetoprotein as a tumor marker].
    Ruibal A; Guarga A; Encabo G; Urrutia A
    Med Clin (Barc); 1985 Nov; 85(16):687-8. PubMed ID: 2417068
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum alpha-fetoprotein and hepatocellular carcinoma size.
    Piantino P; Fusaro A; Daziano E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):131. PubMed ID: 2480412
    [No Abstract]   [Full Text] [Related]  

  • 7. Fucosylation of alpha-fetoprotein in hepatocellular carcinomas.
    Buamah PK; Cornell C; Cassells-Smith AJ; Harris AL
    Lancet; 1986 Apr; 1(8486):922-3. PubMed ID: 2421123
    [No Abstract]   [Full Text] [Related]  

  • 8. Excessive alpha-fetoprotein concentrations in hepatocellular carcinoma.
    Amery AH; Alston WC; Kohn J; White WF
    Br Med J; 1977 Sep; 2(6087):611-2. PubMed ID: 71184
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognostic marker of serum alpha-fetoprotein levels in hepatocellular carcinoma: retrospective analysis of 230 patients].
    Fernández-Ruiz M; Guerra-Vales JM; Ferrando-Vivas P; de la Cruz-Bertolo J
    Med Clin (Barc); 2008 Jul; 131(5):196-7. PubMed ID: 18674491
    [No Abstract]   [Full Text] [Related]  

  • 10. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum alpha-fetoprotein in experimental hepatocellular carcinomas in rats.
    Gopal Naidu NR; Aikat BK; Dash RJ; Sehgal S
    Eur J Cancer (1965); 1978 Mar; 14(3):295-301. PubMed ID: 75796
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.
    Kilickap S; Arslan C; Senel S; Ataseven H
    J Clin Oncol; 2010 Feb; 28(6):e99; author reply e100. PubMed ID: 20085931
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum alpha-fetoprotein and hepatitis B surface antigen in patients with hepatocellular carcinoma (author's transl)].
    Kao MC; Yin SJ; Lee SC; Lin CY; Cheng TC; Fong MS
    Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):1032-7. PubMed ID: 6166727
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
    Wong IH; Lo YM; Yeo W; Lau WY; Johnson PJ
    Clin Cancer Res; 2000 Sep; 6(9):3516-21. PubMed ID: 10999738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
    Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
    Chen DS; Sung FL
    Gastroenterology; 1978 Jan; 74(1):163-4. PubMed ID: 72701
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of the model for end-stage liver disease and serum alpha-fetoprotein as prognostic predictors for hepatocellular carcinoma.
    Huo TI; Lee SD
    Liver Int; 2006 Dec; 26(10):1300-1. PubMed ID: 17105599
    [No Abstract]   [Full Text] [Related]  

  • 20. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
    Wong CB; Attar BM; Shimoda SS
    Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.